Today's Alert

RVVQF is back to DOMINATE the Canadian Cannabis Market! See why Barchart rates “STRONG BUY”…

Posted on by in Today’s Alert

RavenQuest BioMed Inc.
USA:  RVVQF  |  Canada:  RQB  |  Germany: 1IT.F
Last Price: .75  |  Website  |  SEC Filings  |  Latest News

Some of you might be wondering why we have been covering the Legal/Medical Marijuana Sector so frequently.

Well, think about it…

Canada is now just 1 WEEK from enacting the Full Legalization of this controversial plant.

This will NEVER happen again.  There will NEVER be another Banned Substance made legal on this scale, creating a future TRILLION Dollar Global Market and potential BILLION Dollar Corporations.

Indeed, this Sector BOOM is ONCE-IN-A-LIFETIME.

As they say, “The GREEN RUSH is ON”  and $12 BIL is up for Grabs as Canada Legalizes Cannabis!

This is why there may be NO BETTER TIME than Right Now to consider this week’s New Profile…RVVQF (RavenQuest BioMed Inc)!

Since bottoming-out this Summer, RVVQF has come back with sheer vengeance with a nearly 200% Gaining rally!

Now trading in a Strong and sustained Bullish Trend, a return to 52 Week Highs of 2.50 would give it over 242% UPSIDE POTENTIAL!  See Below…

To top it all off, technical analysis site, recently UPGRADED RVVQF to it’s Top Rating of “STRONG BUY”!

In addition, now gives RVVQF an overall “Bullish” Rating with a “VERY BULLISH” Rating in the Intermediate term!

So how will RVVQF continue this epic Bullish trend?  Keep reading…


RavenQuest is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services and specialized research & development.

RavenQuest is a LICENSED PRODUCER with facilities located in Markham, Ontario and Edmonton, Alberta. 

New to the US Markets as of just this February, RVVQF presents a potential “GROUND FLOOR” Opportunity into the Red Hot Marijuana/Cannabis Sector!

The company’s business model uniquely provides investors with the certainty of near-term revenue and the upside of production growth through licensed production facilities.

This is achieved using a diversified FOUR PILLARS approach:

It is believed that the Canadian Federal government will grant 20% of all future Cannabis production to Indigenous PeoplesSo RVVQF has developed an indigenous-centered, end-to-end solution for Cannabis production and sale on sovereign land.

As part of these programs, the company provides sovereign nations with the technical know-how, staff resources, and financing opportunities in exchange for a percentage ownership in the facilities.

These partnerships could lead to a steady stream of positive announcements of new production licenses over the coming quarters as well as favorable taxation benefits – a huge advantage!

RVVQF has already engaged with an impressive list of prospective Indigenous Peoples partners and anticipates that many of these engagements will begin as simple service contracts to build facilities that evolve into partnerships with equity interests.

In fact, RVVQF has already hit the ground running with its partnership with Fort McMurray #468 First Nation!

Per the Agreement, the company will provide its expertise to deliver the technical know-how, staff resources, and financing opportunities as they relate to the development of the Production Facility, initially sized at 24,000 square feet (but is intended to be rapidly expanded to 250,000 sq ft!!). In consideration, RavenQuest will receive a 30% ownership interest in such a facility.

And in more recent news, RVVQF signed a contract with Alexander First Nation, to develop a Cannabis License application, marking a huge first step toward a brighter economic future for both the Indigenous group and the company’s shareholders.

The indigenous Alexander First Nation is located next to the Edmonton Metro region, which has a population of over 1.3 million residents, and plans to build a cannabis facility on its sovereign land.

RVVQF’s deals with Fort McMurray #468 First Nation and the Alexander First Nation underscores the company’s ability to execute on its Indigenous Peoples’ agreements, as well as shows how the company’s four pillars work together.

While so many producers stay local, RVVQF has made great strides to create a presence NATIONWIDE in Canada.

This gives the company a tremendous competitive advantage over it’s peers and could truly pay off when Canada legalizes on Oct 17!

RVVQF first acquired 100% of Edmonton-based Alberta Green Biotech with the intention to build out a 35,500 square-foot facility by mid-2018.

Now referred to as their “Edmonton Facility”, RVVQF is in the final stages of acquiring its license to produce medical marijuana under the federal Marijuana for Medical Purposes Regulations.

The company dedicated to producing the finest quality products for patients suffering from chronic pain, seizures, nausea, anxiety, muscle spasms, insomnia and loss of appetite.

At capacity, the facility will produce 7,000 Kg of cannabis annually, a yield per square foot substantially higher than competitors. The Investment division will continuously add to its portfolio.

In March, RVVQF also announced the Acquisition of BLOOMERA – an Ontario-based producer of cannabis under the Access to Cannabis for Medical Purposes Regulations.

Bloomera currently holds a Health Canada License to Cultivate and and has completed the first of two harvests required by Health Canada for license to sell and dispense.

Known as the Toronto “Markham Facility”, RVVQF will initially add approximately 2,000 kg of annual production of cannabis to their investment division and eventually expected to produce 4,000 kg!

The 20,000 sq. ft. state-of-the-art indoor facility is located only 30km from downtown Toronto, in Markham, serving as a prime distribution hub to the east coast and Canada’s most populous market (Greater Toronto Area).

RVVQF’s most recent Producer Acquisition could be the company’s BIGGEST yet!

In June, the company announced an Letter of Intent to acquire 100% of Western AgriPharma Limited –  a late stage applicant with Health Canada in the development of a 125,000 square foot facility, purpose-built for the production of cannabis in Port Mellon, on British Columbia’s Sunshine Coast.

“Using our proprietary grow methodologies, 125,000 square feet is more like two or three times that footprint, when you factor in what our Orbital Gardening can produce in grams-per-square-foot,” George Robinson, CEO of RavenQuest.

With a full build-out of all of RVVQF’s facilities, the company expects production to grow from 11,000 kilograms of cannabis annually to OVER 50,000 KG!!!!

RVVQF’s business model provides immediate and increasing cash flow, which substantially limits the cash burn traditionally associated with early stage Cannabis companies. The company’s consultancy division carries a lengthy list of licensed and late-stage applicant clients.

In fact, this Service Division produced $611,000 in Revenue in the most recent quarter, covering all operational expenses for the company!

Under this division, RVVQF will offer it’s proprietary ORBITAL GARDENING 2.0 Technology!

The RavenQuest OG2.0 (right) allows for production of large quantities of cannabis in smaller areas by maximizing the productivity of grow space and lighting.

The OG2.0 stacks three-high and two-wide. These six-stacks allow for “three-dimensional”, “cubic-foot” cannabis production, and is fully automated for minimal visits into the grow room.

This rotating garden system uses four 600-watt bulbs to result in eight pounds of yield per garden within eight weeks. That’s 1,500 grams per square foot, compared to the industry average of 130 grams per square foot!!!

Think of it as like a ferris wheel of cannabis slowly revolving around a strong grow light in the center.  How cool is that!!

The Orbital Gardening strategy is a part of what the company calls “Cannabis 2.0”, an environmentally friendly and entirely sustainable approach to growing. [Read More about this Technology]

RVVQF has entered into a Landmark Research Partnership with Canada’s top-ranked McGill University, prioritizing plant stabilization and the maximization of flower production in Cannabis plants.

The work will be conducted through collaboration between two McGill laboratories and constitute a set of experiments that will increase scientific understanding of Cannabis genetics, breeding and production.

The Partnership will focus upon three key issues facing the cannabis industry:

1. Cannabis Cultivar Recognition & Identification
2. Cannabis Plant Stabilization
3. Cannabis Cultivation and Yield Improvements

McGill’s doctor Donald Smith is a leading researcher and holds patented technologies related to enhanced plant yield.  The focus will be to maximize yield-per-square-foot for better efficiency, smaller environmental footprint and lower production costs per kg.

This partnership with McGill is a HUGE Competitive Advantage for RVVQF as they anticipate superior yields, cost, and production through this research!

“Canada will become only the second country in the world to legalize recreational cannabis. Safety starts with understanding the genetic/genomic basis of plant productivity and this partnership will contribute to build this knowledge,”

If you haven’t sensed it yet, RVVQF’s Four Pillars all work in conjunction with each other to create, what the company hopes to be, a Cannabis POWERHOUSE!

So let’s break it down…

Through their Indigenous Peoples Division, the company can strategically partner with tribes/first nations across Canada and build facilities with favorable tax breaks to produce Cannabis.

In addition to that, RVVQF will be producing Cannabis through their Investments division, which includes the Acquisitions of Bloomera, Alberta Green Biotech, and Western AgriPharma.

Both of these divisions will be supported by the company’s Management Services Division (which is already a money-maker) by introducing consulting as well as the company’s Orbital Gardening 2.0 Technology.

And lastly, supporting each arm is the Research & Development Division, which, through it’s partnership with McGill University, brings a major scientific advantage from a top-ranked University to figure out ways to increase production and produce better yields!

Just when you thought RVVQF’s rapid growth footprint couldn’t grow any larger, the company announced it’s intent to purchase a Majority Stake in “micro-cultivator”, Elephant Extracts!

Elephant Extracts makes a welcome and strategic addition to RVVQF’s portfolio with it’s vast knowledge of extraction technology.   Read below….

RavenQuest Announces Intent To Purchase Majority Stake In Elephant Extracts

VANCOUVER, British Columbia, — RavenQuest BioMed Inc. is pleased to announce that it has entered into a letter of intent with 1090252 B.C. Ltd. (“Elephant Extracts” or “Elephant“) in pursuit of a transaction involving the acquisition of 51% of the outstanding share capital of Elephant Extracts.Elephant Extracts is a license applicant under the Access to Cannabis for Medical Purposes Regulations (“ACMPR“), as well as a distributor of cannabis products and accessories. The Health Canada application for Elephant Extracts includes a 10,000 square foot production facility, which will be classified as a “micro-cultivator” license upon passing of the Cannabis Act in Canada.

RavenQuest CEO, George Robinson, commented, “We are very excited to welcome Trevor Hinds and his team at Elephant Extracts into the RavenQuest family. Elephant’s vast extraction knowledge is a wonderful complement for RavenQuest’s revolutionary and science-based grow methodology, producing a powerful combination.”

“RavenQuest is committed to helping micro-cultivators come into the legalized space across the country,” Robinson continued.

“We expect this will be the first of many micro-cultivators to work with RavenQuest….


Canada’s Cannabis Industry is expected to surpass $22 BIL in size over the coming years, according to Deloitte, with over 200,000 registered medical marijuana patients today.

However, the industry is expected to see a shortfall in supply with the near-term plans to legalize marijuana for recreational use.

As an Licensed Producer, RVVQF will have opportunity in that market.  The company hopes to ramp up to 11,000 kilograms per year ($55 MIL in annual revenue) when fully operational.

RVVQF already forecasts a $15 MIL Revenue Stream on the Management Services side alone for 2018 to 2019, which means the company will have a positive cash flow.

Once its production facilities are up and running, they expect to see $55 MIL in annual revenue on that side of the business!!!

More than any Cannabis company we’ve seen so far, RVVQF truly seems the most ready to capture a sizable portion of Canada’s Cannabis Market!

Full build-out of RVVQF’s facilities moves them to a projected production of 11,000 kg annually to over 50,000 kg annually.

Needless to say, this may put them in league with the big boys like Canopy, Tilray, and more!

RVVQF offers everything from Technology and Consulting to Production and Research.

By diversifying their offerings into each of their divisions, RVVQF has brilliantly created an ecosystem poised for success.

With Canada’s Legalization only 1 week away, there may be no better time for this GROUND FLOOR Situation than right now!

Make sure you put RVVQF on your screen IMMEDIATELY and Follow on Twitter for Updates!


Please read our Full Disclaimer:

This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. The paying party may own shares and may liquidate them during the promotional period.

PLEASE NOTE WELL: and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice.


You are reading this newsletter because you have subscribed via our Opt-In Signup form on our Website. If you have been subscribed by mistake, you may unsubscribe HERE.

This Newsletter is now owned and operated by Link Media. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to Link Media and/or it’s subscriber base. Our website and newsletter are for Entertainment purposes only. This newsletter is NOT a source of unbiased information. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. Full disclaimer can be read at

We encourage all to read the SEC INVESTOR ALERT before reading our Newsletter.

Release of Liability: Through use of this email and/or website advertisement viewing or using you agree to hold, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by or an offer or solicitation to buy or sell any security.

COMPENSATION: has been compensated one-hundred and fifty thousand dollars cash via bank wire by RavenQuest BioMed Inc. for a one week advertising services contract. does not own any shares of RVVQF.

All Content, Distribution, and editorial control has been given, reviewed, and approved by RavenQuest BioMed Inc. has been previously compensated one-hundred and fifty thousand dollars cash via bank wire by RavenQuest BioMed Inc. for a one week advertising services contract which has expired. does not investigate the background of any company or third party. The company or third party may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. may purchase shares on the open market of any mentioned company following the dissemination of this email. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Further, has no advance knowledge of any future events of the profiled companies which includes, but is not limited to, news & press releases, changes in corporate structure, or changes in share structure.

None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. is compliant with the Can Spam Act of 2003. does not offer such advice or analysis, and further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day closing price and the high of day price during our promotional coverage.

In preparing this publication, has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this email and website are believed to be reliable, however, and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. is not responsible for any claims made by the companies advertised herein, nor is responsible for any other promotional firm, its program or its structure.